vimarsana.com

Page 8 - நிறுவனம் ஆஃப் உயிரியல் ப்ராடக்ட்ஸ் இணை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MIL-OSI China: WHO endorses China s Sinopharm COVID-19 vaccine, giving boost to global jab rollout

Source: China State Council Information Office The World Health Organization (WHO) validated on Friday the COVID-19 vaccine developed by China’s Sinopharm for emergency use, a move set to boost global vaccine rollout, particularly in the developing world. “This afternoon, the WHO gave emergency use listing to Sinopharm Beijing’s COVID-19 vaccine, making it the sixth vaccine to receive WHO validation for safety, efficacy and quality,” said WHO Director General Dr. Tedros Adhanom Ghebreyesus at a press briefing. “This expands the list of vaccines that COVAX can buy and gives countries confidence to expedite their own regulatory approval, and to import and administer a vaccine,” he said.

WHO endorses China s Sinopharm COVID-19 vaccine, giving boost to global jab rollout_GMW cn

2021-05-08 13:09   By: Xinhua   A Palestinian man receives the second dose of Chinese Sinopharm COVID-19 vaccine at a medical center during a vaccination campaign in the West Bank city of Bethlehem, April 29, 2021. (Photo by Luay Sababa/Xinhua) With the WHO s validation for emergency use, the Sinopharm vaccine, as the first COVID-19 vaccine developed by a non-western country, is expected to accelerate vaccine rollout in many low and middle-income countries through purchase and delivery by the WHO-led COVAX initiative. GENEVA, May 7 (Xinhua) The World Health Organization (WHO) validated on Friday the COVID-19 vaccine developed by China s Sinopharm for emergency use, a move set to boost global vaccine rollout, particularly in the developing world.

The Latest: WHO endorses China s Sinopharm COVID-19 vaccine, giving boost to global jab rollout

news The Latest: WHO endorses China s Sinopharm COVID-19 vaccine, giving boost to global jab rollout Liu Qu © Provided by N.C.N. Limited  A Palestinian man receives the second dose of Chinese Sinopharm COVID-19 vaccine at a medical center during a vaccination campaign in the West Bank city of Bethlehem, April 29, 2021. (Photo by Luay Sababa/Xinhua) With the WHO s validation for emergency use, the Sinopharm vaccine, as the first COVID-19 vaccine developed by a non-western country, is expected to accelerate vaccine rollout in many low and middle-income countries through purchase and delivery by the WHO-led COVAX initiative.  GENEVA, May 7 (Xinhua) The World Health Organization (WHO) validated on Friday the COVID-19 vaccine developed by China s Sinopharm for emergency use, a move set to boost global vaccine rollout, particularly in the developing world.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.